Pharmaceutical group ยท Sweden
Ferring
A group of 23 companies with 339 medicines in 12 countries.
Loading your pageโฆ
Loading your pageโฆ
Pharmaceutical group ยท Sweden
A group of 23 companies with 339 medicines in 12 countries.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
23 companies in 15 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 339
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| A.P.L.10,000 units/vial | 20,000 units/vial | 5,000 units/vial ยท Injectable | Gonadotropin, Chorionic | United States | Not marketed | 1974 |
| acetato de atosibana | Atosiban | Brazil | Authorised | 2018 |
| ACTHREL0.1mg base/vial ยท Injectable | Corticorelin ovine triflutate | United States | Marketed | 1996 |
| ADSTILADRIN300000000000 vp / ml ยท Suspension | Nadofaragene firadenovec | Canada | Authorised | |
| Adstiladrin3x10^11 viral particles (vp)/mL ยท For Suspension | Nadofaragene firadenovec | United States | Marketed | 2022 |
| ADSTILADRINSospensione endovescicale | Nadofaragene firadenovec | Italy | Authorised | |
| ADSTILADRIN 3 ร 1011 virusdeeltjes/ml intravesicale suspensieSuspensie voor intravesicaal gebruik | Nadofaragene firadenovec | Netherlands | Authorised | 2026 |
| BIO-TROPIN4.8mg/vial ยท Injectable | Somatropin | United States | Not marketed | 1995 |
| BRAVELLE75 iu/vial ยท Injectable | Urofollitropin | United States | Not marketed | 2002 |
| BRAVELLE0.9% ยท Injectable | Urofollitropin | United States | Marketed | 2002 |
| CERVIDIL10mg ยท Insert, extended release | Dinoprostone | United States | Marketed | 1995 |
| CERVIDIL10 mg / insert ยท Insert | Dinoprostone | Canada | Marketed | 1997 |
| Cervidil Vaginal Delivery System 10mg10mg ยท Other | Dinoprostone | Singapore | Authorised | 2011 |
| CLENPIQ12gm/bot; 3.5gm/bot; 10mg/bot ยท Solution | Citric acid, Magnesium oxide, Picosulfate | United States | Marketed | 2017 |
| CONCENTRAID0.01% ยท Solution | Desmopressin | United States | Not marketed | 1990 |
| CORAMENT | Budesonide | Brazil | Authorised | 2020 |
| CORTIMENTCompressa a rilascio prolungato | Budesonide | Italy | Authorised | |
| CORTIMENT9 mg ยท Tablet (Delayed- And Extended-Release) | Budesonide | Canada | Marketed | 2016 |
| Cortiment 9 mg, tabletten met verlengde afgifteTablet met verlengde afgifte | Budesonide | Netherlands | Authorised | 2013 |
| Cortiment MMX 9 mg tablete s produljenim oslobaฤanjemtableta s produljenim oslobaฤanjem | Budesonide | Croatia | Marketed | 2018 |
| CORTIMENT PROLONGED RELEASE TABLETS 9 MG9.0 mg ยท Tablet, film coated, extended release | Budesonide | Singapore | Authorised | 2017 |
| DDAVP | Desmopressin | Brazil | Authorised | 2007 |
| DDAVP0.1mg | 0.2mg ยท Tablet | Desmopressin | United States | Marketed | 1995 |
| DDAVP0.01MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** ยท Spray, metered | Desmopressin | United States | Not marketed | 1978 |
| DDAVP0.01% ยท Solution | Desmopressin | United States | Not marketed | 1978 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 60 | 24 | 36 | CompaniesAll medicines |
| Spain | 45 | 36 | 9 | CompaniesAll medicines |
| Netherlands | 37 | 37 | 0 | CompaniesAll medicines |
| Singapore | 30 | 30 | 0 | CompaniesAll medicines |
| United States | 30 | 30 | 0 | CompaniesAll medicines |
| Romania | 27 | 0 | 27 |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
| CompaniesAll medicines |
| Serbia | 27 | 26 | 1 | CompaniesAll medicines |
|---|
| Brazil | 25 | 17 | 8 | CompaniesAll medicines |
|---|
| Saudi Arabia | 22 | 22 | 0 | CompaniesAll medicines |
|---|
| Croatia | 18 | 18 | 0 | CompaniesAll medicines |
|---|
| Italy | 14 | 14 | 0 | CompaniesAll medicines |
|---|
| European Union (EMA) | 4 | 3 | 1 | CompaniesAll medicines |
|---|
Also in the registers of France, United Kingdom
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Czech Ministry of Finance, ARES; Ministry of Justice commercial register (VR), Czech Statistical Office (RES), exact IฤO, source record datumAktualizace and retrieval date. Structured extraction by Prognia.
Licence: Czech statutory open data; ARES reuse and operating terms
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sฤnฤtฤศii, Catalogul public naลฃional al preลฃurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.